FDA Import Refusal SCS-2848659-6/11/1 — Johnson & Johnson
The FDA refused shipment SCS-2848659-6/11/1 from Johnson & Johnson (Canada) on Jan 28, 2019. The refused product falls under Drugs and Biologics — POLYMYXIN B SULFATE (PEPTIDES). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 28, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 56FBY30 POLYMYXIN B SULFATE (PEPTIDES)
- Charges
- 75